Last reviewed · How we verify
NCT04237727: CAvent
CAvent-Ventilation During Advanced Cardiopulmonary Resuscitation in Out-of-hospital Cardiac Arrest- an Observational Study
trial testing Fluxmed GrH portable pneumotachograph in Out-of-Hospital Cardiac Arrest in 241 participants. Completed in 1 December 2025.
31 August 2025
Quick facts
| Lead sponsor | Uppsala University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 241 |
| Start date | 1 May 2019 |
| Primary completion | 31 August 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 5 locations across Sweden, Netherlands |
Drugs / interventions tested
- Fluxmed GrH portable pneumotachograph
Conditions studied
- Out-of-Hospital Cardiac Arrest — all drugs for Out-of-Hospital Cardiac Arrest →
- Pulmonary Ventilation — all drugs for Pulmonary Ventilation →
Sponsor
Uppsala University
Who can join
18 and older, any sex, with Out-of-Hospital Cardiac Arrest or Pulmonary Ventilation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this observational study is to investigate how ventilations is given during cardiopulmonary resuscitation (CPR) given by advanced life support providers (ALS). A portable device capable of detailed measurments of ventilation will be used when ventilating patients suffering cardiac arrest. The main objective of the study is to describe the ventilatiosn given in terms of volume, frequency and pressure, both overall and during different CPR modes and when using different methods to handle the patients airway.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04237727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Out-of-Hospital Cardiac Arrest
Currently open trials in the same condition.
- NCT03222999 — Korean Cardiac Arrest Research Consortium · recruiting
Other Uppsala University trials
Trials by the same sponsor.
- NCT07517185 — The HIt HArd and hiT Early in Multiple Sclerosis Trial · Phase 2 · not yet recruiting
- NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
- NCT07461636 — Robotic-Assisted Pedicle Screw Placement in Spine Surgery · recruiting
- NCT07273409 — Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not · NA · recruiting
- NCT07352683 — Open TAP-block in Pediatric Abdominal Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04237727 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Uppsala University
- Last refreshed: 7 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04237727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing